Analytical Sample Clauses

Analytical o Draft release Specifications for API, raw materials, and bulk packaging components for Client approval. o Conduct API, raw material, and bulk packaging component release testing; execute API ID test method (HPLC) transfer protocol from Client. o Draft equipment procedure documents using Client supplied analytical method and equipment protocols and procedures for Client approval. o Conduct Sterility and Endotoxin (LAL) testing of the Product. o Supply Certificate of Testing for Sterility and Endotoxin testing of Product to Client. o Qualify Endotoxin (LAL) method on one (1) batch of AI-850.
View SourceView Similar (2)
Analytical. Analytical disputes must be based upon laboratory analysis utilizing the appropriate Enterprise methodology. Analytical disputes must be made within forty-five
View SourceView Similar (2)
Analytical. Analytical disputes must be based upon laboratory analysis, using the Carrier-specified test method, of both the Carrier sample and the Shipper sample from the custody sampler (as described above). After analyzing their respective samples according to the Carrier-specified test method, if Shipper and Carrier are in disagreement, then they shall each send the other a copy of their respective sample results, and if the sample results differ by more than the GPA 2186/2177 reproducibility limits for one or more components, then the referee sample shall be taken to Coastal Flow Measurement, which shall analyze the sample in accordance with the Carrier-specified test method. If the third-party laboratory and Carrier analyses disagree by more than the GPA 2186/2177 reproducibility limits for one or more Components, then the third-party lab results shall be accepted by Shipper and Carrier as final and conclusive for the composition of the stream. If the third-party laboratory and Carrier analyses agree within the reproducibility limits of GPA 2186/2177, then the Carrier analysis shall be accepted by Shipper and Carrier as final and conclusive for the composition of the stream.
View Source
Analytical. ‌ Internal quality control was done and well trained technologists performed the test according to the SOP.
View Source
Analytical. Methods will be developed by [ * ] for QC release, characterization, subidentification, potency, and activity prior to the IND submission. [ * ] will [ * ] the release assays for both bulk and product to [ * ].
View Source
Analytical. A report summarizing available data describing the physical properties of the drug substance, including MW, solubility, pI, etc as applicable.
View Source
Analytical. Contractor shall have access to State certified analytical facilities capable of performing chemical analyses on 24-hour turnaround bases. Standard turnaround time for laboratory analysis shall be 48 hours or less. Laboratories performing chemical analyses for the Contractor shall be certified by the California State Water Resources Control Board, Environmental Laboratory Accreditation Program (SWRCB-ELAP) for the specific required cleanup analyses. Mobile laboratory units shall be certified by SWRCB, for the specific cleanup analyses. Laboratory methods not certified by SWRCB may be performed by laboratories only if recognized by SWRCB for comparable test methods or if the laboratory is certified as a US EPA Contract laboratory.
View Source
Analytical. Analytical test methods, qualification or validation protocols and reports for the methods to be transferred, and list of reagents required within [*] of the effective date of the Agreement.
View Source
Analytical. Analytical disputes must be based upon laboratory analysis, using the Enterprise-specified test method, of both the Enterprise sample and the Customer sample from the custody sampler (as described above). After analyzing their respective samples according to the Enterprise-specified test method, if Customer and Enterprise are in disagreement, then they shall each send the other a copy of their respective sample results, and if the sample results differ by more than the GPA 2186/2177 reproducibility limits for one or more components, then the referee sample shall be taken to a mutually agreed upon third-party laboratory, which shall analyze the sample in accordance with the Enterprise-specified test method. If the third-party laboratory and Enterprise analyses disagree by more than the GPA 2186/2177 reproducibility limits for one or more components, then the third-party lab results shall be accepted by Customer and Enterprise as final and conclusive for the composition of the stream. If the third-party laboratory and Enterprise analyses agree within the reproducibility limits of GPA 2186/2177, then the Enterprise analysis shall be accepted by Customer and Enterprise as final and conclusive for the composition of the stream. Section
View Source

Related to Analytical

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Laboratory a. Drug tests shall be conducted by laboratories licensed and approved by SAMSHA which comply with the American Occupational Medical Association (AOMA) ethical standards. Upon advance notice, the parties retain the right to inspect the laboratory to determine conformity with the standards described in this policy. The laboratory will only test for drugs identified in this policy. The City shall bear the cost of all required testing unless otherwise specified herein. b. Tests for all controlled substances, except alcohol, shall be by oral fluid testing and shall consist of two procedures, a screen test and, if that is positive, a confirmation test. c. To be considered positive for reporting by the laboratory to the City, both samples must be tested separately in separate batches and must also show positive results on the confirmatory test. d. In the event of a positive test, the testing laboratory will perform an automatic confirmation test on the original specimen at no cost to the Covered Employee. In addition, the testing laboratory shall preserve a sufficient specimen to permit an independent re-testing at the Covered Employee’s request and expense. The same, or any other, approved laboratory may conduct re-tests. The laboratory shall endeavor to notify the designated MRO of positive drug, alcohol, or adulterant tests results within five (5) working days after receipt of the specimen.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.